Author

Emily Back

Observed names: Back, Emily, E Back

Institution: DHT.health (United Kingdom)

Observed institution: DHT.health (United Kingdom)

ORCID: 0000-0002-2786-8331

Observed ORCID: 0000-0002-2786-8331

OpenAlex ID: A5010839283

The value-based price of transformative gene therapy for sickle cell disease: a modeling analysis

2024 · George Morgan, Emily Back, et al. · Scientific Reports · 15

Assessing the value of bypassing agent therapy used prophylactic versus on-demand, during immune tolerance induction for treatment of inhibitors: a retrospective chart review

2023 · George Morgan, Emily Back, et al. · Orphanet Journal of Rare Diseases · 2

PCR64 Examining the Disability Paradox and Health State Utility Valuation in Achondroplasia

2024 · G Morgan, E Back, et al. · Value in Health · 1

Clinical and economic impact of rFVIIa prophylaxis in Glanzmann thrombasthenia: cohort analysis in Saudi Arabia

2026 · Ahmad Tarawah, Sami Albattat, et al. · Blood Vessels Thrombosis & Hemostasis

PB3424 The economic burden of von Willebrand Disease in the United Kingdom: Insights from the PIVOT-vWD UK cohort

2026 · Sarah Brighton, Robert Sidonio, et al. · Research and Practice in Thrombosis and Haemostasis

The economic burden of von Willebrand Disease in the United Kingdom: Insights from the PIVOT-vWD UK cohort

2026 · Sarah Brighton, Robert Sidonio, et al.

Caregiver Challenges in von Willebrand Disease: Insights from the PIVOT-vWD UK Study

2026 · Brighton, Sarah, Morgan, George, et al.

Diagnostic Challenges and Unmet Needs among Women and Girls with von Willebrand Disease (vWD) in the UK: Findings from the UK cohort of the PIVOT-vWD Evidence and Insights Programme

2026 · Back, Emily, Brighton, Sarah, et al.

Expanding the PIVOT-vWD Programme: An International Direct-to-Patient Study to Capture the Impact, Voice, and Outcomes of von Willebrand Disease

2026 · Morgan, George, Sidonio, Robert, et al.

PCR42 Characterizing the UK Population Living With Von Willebrand Disease: Foundational Data for Health Economics and Outcomes Research

2025 · George Morgan, Emily Back, et al. · Value in Health

PCR23 Assessing the Sensitivity of EQ-5D-5L and AQoL-4D to Disease Severity in Von Willebrand Disease: Findings From UK Cohort of the PIVOT-vWD Study

2025 · George Morgan, Emily Back, et al. · Value in Health

Works count: 11

Citation count: 18

H-index: 2

I10-index: 1